```html

Herpes Simplex Virus (HSV‑1) – Comprehensive Medical Guide

Overview

Herpes simplex virus type 1 (HSV‑1) is a common, lifelong viral infection that primarily causes oral lesions (cold sores) but can also affect the genital area, eyes, and skin. It belongs to the Herpesviridae family, which also includes HSV‑2, varicella‑zoster (chickenpox), and Epstein‑Barr virus.

Key points:

• Prevalence: According to the World Health Organization (WHO), roughly 67% of the global population under age 50 carries HSV‑1. In the United States, the CDC estimates that about 50‑80% of adults are seropositive.
• Age of acquisition: Most people acquire HSV‑1 in childhood through non‑sexual contact (e.g., sharing utensils, lip‑kiss). However, genital HSV‑1 infections have risen, now accounting for up to 30% of new genital herpes cases in young adults.
• Who it affects: All genders, races, and socioeconomic groups can be infected. Immunocompromised individuals (e.g., HIV‑positive, transplant recipients) are at higher risk for severe disease.

Symptoms

HSV‑1 infection can be asymptomatic (no noticeable signs) in up to 80% of people. When symptoms appear, they typically follow a predictable pattern.

Primary (Initial) Infection

• Prodrome: Tingling, itching, or burning sensation 1‑2 days before lesions appear.
• Oral lesions: Clustered vesicles on the lips, gums, or inside the mouth that rupture to form painful ulcers.
• Fever, malaise, headache, muscle aches – especially in children.
• Swollen lymph nodes in the neck or behind the ears.
• Genital involvement: Rare but can present as painful genital ulcers following oral‑genital contact.

Recurrent Outbreaks

• Triggering prodrome (tingling, itching) that may last several hours.
• Small, painful vesicles that crust over within 7‑10 days.
• Outbreaks are usually milder and shorter than the primary infection.
• Frequency varies widely – some people have several episodes per year; others have none after the first episode.

Other Manifestations

• Eczema herpeticum: Widespread HSV infection superimposed on eczema or atopic dermatitis.
• Herpetic whitlow: Painful lesions on the fingers, often seen in healthcare workers.
• Herpes keratitis: Infection of the cornea that can cause vision loss if untreated.
• Encephalitis: Rare but serious brain inflammation, occurring most often in infants or immunocompromised adults.

Causes and Risk Factors

HSV‑1 is spread through direct contact with infected bodily fluids or skin.

Modes of Transmission

• Oral‑oral contact: Kissing, sharing utensils, lip balm, or drinks.
• Oral‑genital contact: Oral sex can transmit HSV‑1 to the genital area.
• Contact with lesions: Touching an active cold sore and then touching another body site.
• Mother‑to‑child: Rarely during childbirth if the mother has an active genital HSV‑1 infection.

Risk Factors

• Age < 20 years (higher exposure through kissing).
• Living in crowded settings (dorms, military barracks).
• Having a partner with a known HSV‑1 infection.
• Immunosuppression (HIV, organ transplant, chemotherapy).
• Existing skin conditions (eczema, psoriasis) that disrupt the skin barrier.
• Frequent oral‑genital sexual activity without barrier protection.

Diagnosis

Accurate diagnosis guides appropriate management and counseling.

Clinical Evaluation

• Visual inspection of typical lesions (grouped vesicles on an erythematous base).
• Review of symptom chronology (prodrome, lesion evolution).

Laboratory Tests

• Polymerase chain reaction (PCR): Detects HSV DNA from lesion swabs or cerebrospinal fluid (gold standard for encephalitis).
• Viral culture: Less sensitive than PCR; useful in resource‑limited settings.
• Direct fluorescent antibody (DFA) testing: Rapid but requires expertise.
• Serologic testing (IgG/IgM antibodies): Determines prior exposure; not useful for acute diagnosis of a new lesion.

When to Order Tests

• Atypical lesions or first‑time presentation.
• Suspected HSV‑1 keratitis or encephalitis.
• Pregnant women with genital lesions (to differentiate HSV‑1 from HSV‑2).

Treatment Options

There is no cure for HSV‑1, but antiviral therapy can reduce severity, shorten duration, and lower transmission risk.

Antiviral Medications

Drug	Typical Dose (Adults)	Use
Acyclovir	200 mg five times daily (5‑day course)	First‑episode oral lesions; suppressive therapy 400 mg BID
Valacyclovir	1 g twice daily (5‑day course)	Preferred for better bioavailability; also 500 mg BID for suppressive therapy
Famciclovir	500 mg twice daily (5‑day course)	Alternative for patients intolerant to acyclovir

Topical antivirals (e.g., acyclovir 5% cream) have limited benefit; oral therapy is recommended for most cases.

When to Initiate Treatment

• Within 72 hours of lesion onset for maximal benefit.
• Immunocompromised patients (even early lesions).
• Pregnant women with genital HSV‑1 (to reduce fetal risk).
• Patients with severe or atypical presentations (e.g., ocular involvement).

Adjunctive Measures

• Analgesics: Ibuprofen or acetaminophen for pain/fever.
• Topical lidocaine or benzocaine patches for localized discomfort.
• Cold compresses to reduce swelling.

Lifestyle Modifications

• Avoid touching lesions; wash hands frequently.
• Do not share lip balms, utensils, or towels during an outbreak.
• Use barrier protection (condoms, dental dams) during oral‑genital contact, even when lesions are absent (asymptomatic shedding can occur).
• Stress‑management techniques—stress is a common trigger for recurrences.

Living with Herpes Simplex Virus (HSV‑1)

While a diagnosis can be emotionally challenging, most people lead normal, healthy lives.

• Education & communication: Inform sexual partners; most adults appreciate honesty.
• Record‑keeping: Note trigger patterns (stress, sun exposure, illness) to anticipate outbreaks.
• Sun protection: UV light can precipitate lip lesions—use SPF 30+ lip balm.
• Immunity support: Balanced diet, adequate sleep, and regular exercise help maintain a robust immune response.
• Psychological support: Counseling or support groups can alleviate stigma and anxiety.
• Pregnancy considerations: Discuss HSV status with obstetrician; antiviral suppressive therapy in the third trimester reduces neonatal transmission risk.

Prevention

Because HSV‑1 is highly contagious during active lesions and through asymptomatic shedding, prevention focuses on reducing exposure.

• Barrier methods: Use condoms or dental dams during oral‑genital contact.
• Avoid direct contact: Refrain from kissing or sharing items with someone who has an active cold sore.
• Hand hygiene: Wash hands with soap and water after touching lesions.
• Sun protection: Apply lip sunscreen to prevent UV‑triggered recurrences.
• Vaccination research: No approved HSV vaccine exists yet, but clinical trials are ongoing (NIH, 2023).

Complications

Most HSV‑1 infections resolve without lasting problems, but complications can arise, particularly in vulnerable populations.

• Herpes keratitis: Recurrent infection of the cornea may lead to scarring and vision loss; requires prompt ophthalmology referral.
• Eczema herpeticum: Rapidly spreading lesions in patients with eczema; can become life‑threatening.
• Neonatal herpes: Extremely rare with HSV‑1 (more common with HSV‑2), but can occur if a mother transmits during delivery.
• Encephalitis: HSV‑1 is the most common cause of sporadic viral encephalitis; presents with fever, headache, seizures, and altered mental status.
• Psychosocial impact: Stigma, anxiety, and depression are frequent and may affect relationships and quality of life.

When to Seek Emergency Care

For non‑emergency concerns, contact your primary care provider, dermatologist, or infectious‑disease specialist.

---

Sources: Mayo Clinic, CDC, WHO, NIH, Cleveland Clinic, Journal of Infectious Diseases (2022), Ophthalmology Science (2023).

```